IL6 and breast carcinoma: GSEA demonstrated that 4T1 breast cancers could still activate the IL-6 signaling and inflammatory response in the absence of Saa1-2 genes (Figure 3B), suggesting a subtle or negligible contribution of Saa1-2 to the liver transcriptome in our experimental settings.